Edesa Biotech, Inc. — Director's Dealing 2019

Jul 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2019-07-26

Reporting Person: Nijhawan Pardeep (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-26	Common Shares	A	30183	—	Acquired	537312	Direct
2019-07-26	Common Shares	A	118345	—	Acquired	2106769	Indirect
2019-07-26	Common Shares	A	12588	—	Acquired	224094	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-26	Stock Option (right to buy)	$2.16	A	2667	Acquired	2027-09-26	Common Shares (2667)	Direct
2019-07-26	Stock Option (right to buy)	$2.16	A	91	Acquired	2028-12-28	Common Shares (91)	Direct

Footnotes

F1: Represents additional common shares or options to purchase common shares, as applicable, of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.

F2: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.

F3: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan.

F4: In Canadian currency.

F5: This option was issued in replacement of an option to purchase shares of Edesa.

F6: This option vests and becomes exercisable 1/3 on September 26, 2018, and monthly thereafter through September 26, 2020.

F7: This option vests and becomes exercisable 1/3 on December 28, 2019, and monthly thereafter through December 28, 2021.